ketanserin has been researched along with norfenfluramine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arjona, AA; Lee, RK; Pooler, AM; Wurtman, RJ | 1 |
| Fink, GD; Li, MW; Ni, W; Thakali, K; Watts, SW | 1 |
| Bader, M; Lookingland, K; Murphy, DL; Ni, W; Watts, SW; Wilhelm, CS | 1 |
3 other study(ies) available for ketanserin and norfenfluramine
| Article | Year |
|---|---|
Effect of a 5-HT(2C) serotonin agonist, dexnorfenfluramine, on amyloid precursor protein metabolism in guinea pigs.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Body Weight; Brain; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Interactions; Guinea Pigs; Hippocampus; Ketanserin; Male; Norfenfluramine; Peptide Fragments; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin | 2002 |
The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
Topics: Animals; Aorta; Blood Pressure; Ergolines; Fenfluramine; In Vitro Techniques; Ketanserin; Male; Norfenfluramine; Prazosin; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Adrenergic, alpha; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sympathectomy; Sympathetic Nervous System; Vasoconstriction | 2004 |
(+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter.
Topics: Animals; Aorta; Fluoxetine; Fluvoxamine; Ketanserin; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Norfenfluramine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tryptophan Hydroxylase; Vasoconstriction | 2005 |